Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L McCarthy

Showing results (831-840 of 1,098) with videos related to

Pageof 110
Sort By:
Leukemia|March 27, 2009
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplantP N Hari, M-J Zhang, V Roy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Therapeutic Advances in Drug Safety|June 28, 2021
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccinationAllison L Naleway, Bradley Crane, Stephanie A Irving, et al.
Blood|August 26, 1998
Allogeneic bone marrow transplantation for low-grade lymphomaK van Besien, K A Sobocinski, P A Rowlings, et al.
Nature Communications|February 11, 2022
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myelomaMaximilian Merz, Almuth Maria Anni Merz, Jie Wang, et al.
Blood|July 29, 2004
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant RegistryCésar O Freytes, Fausto R Loberiza, J Douglas Rizzo, et al.
Blood Cancer Journal|February 15, 2020
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Andrzej J Jakubowiak, Philip L McCarthy, et al.
Transplantation and Cellular Therapy|May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple MyelomaSarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Transplantation and Cellular Therapy|June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple MyelomaSarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Pageof 110

Showing results (831-840 of 1,098) with videos related to

Sort By:
Pageof 110
Leukemia|March 27, 2009
Is the International Staging System superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplantP N Hari, M-J Zhang, V Roy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 21, 2006
A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remissionDavid I Marks, Stephen J Forman, Karl G Blume, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Therapeutic Advances in Drug Safety|June 28, 2021
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccinationAllison L Naleway, Bradley Crane, Stephanie A Irving, et al.
Blood|August 26, 1998
Allogeneic bone marrow transplantation for low-grade lymphomaK van Besien, K A Sobocinski, P A Rowlings, et al.
Nature Communications|February 11, 2022
Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myelomaMaximilian Merz, Almuth Maria Anni Merz, Jie Wang, et al.
Blood|July 29, 2004
Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant RegistryCésar O Freytes, Fausto R Loberiza, J Douglas Rizzo, et al.
Blood Cancer Journal|February 15, 2020
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Andrzej J Jakubowiak, Philip L McCarthy, et al.
Transplantation and Cellular Therapy|May 23, 2022
Proceedings from the Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Immune and Cellular Therapy in Multiple MyelomaSarah A Holstein, Fotis Asimakopoulos, Abdel Kareem Azab, et al.
Transplantation and Cellular Therapy|June 9, 2021
The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple MyelomaSarah A Holstein, Nizar Bahlis, P Leif Bergsagel, et al.
Pageof 110